Jae Sevelius, PhD

Associate Professor

I am an Associate Professor in Residence with the Center for AIDS Prevention Studies (CAPS), Division of Prevention Sciences, Department of Medicine, at the University of California, San Francisco. I lead several community-based research projects at the Center of Excellence for Transgender Health focused on leveraging data to develop culturally relevant, trauma-informed, and transgender–specific programs and interventions to promote holistic health and wellness among transgender people, with an emphasis on serving transgender women of color and those affected by HIV. I am also a licensed clinical psychologist.
2018 - Diversity, Equity, and Inclusion Champion Training, University of California
Postdoctoral Research Scholar, - Behavioral Medicine, University of California, San Francisco
Bachelor of Science, - Psychology, University of Florida
PhD, - Clinical Psychology, University of Missouri
M.A., - Gender Studies, University of Missouri
Pre-doctoral internship, APA-accredited, - Counseling and Testing Center, University of Oregon
Honors and Awards
  • Mid-career Development Award, UCSF School of Medicine, 2020
  • Outstanding Achievement Award, American Psychological Association, Committee on Sexual Orientation and Gender Diversity, 2018
  • Strengthening Team Science in California, CREDITS - Center for Research, Excellence, and Diversity in Team Science, 2017
  • Early Career Research Excellence Award - Behavioral Science, Gladstone Center for AIDS Research, UCSF, 2016
  • UCSF CORO Faculty Leadership, CORO, UCSF, 2015
  • Innovative Dissemination Award, Center for AIDS Prevention Studies, UCSF, 2010
  1. Couples-based approach to HIV prevention for transgender women and their partners: study protocol for a randomised controlled trial testing the efficacy of the 'It Takes Two' intervention.
  2. We Are All Women: Barriers and facilitators to inclusion of transgender women in HIV treatment and support services designed for cisgender women
  3. Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the iBrEATHe Study.
  4. What sexual and gender minority people want researchers to know about sexual orientation and gender identity questions: a qualitative study
  5. A Pilot Study to Evaluate a Novel Pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection
  6. Research with Marginalized Communities: Challenges to Continuity During the COVID-19 Pandemic.
  7. HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States
  8. Sheroes: Feasibility and Acceptability of a Community-Driven, Group-Level HIV Intervention Program for Transgender Women.
  9. "She is Like a Sister to Me." Gender-Affirming Services and Relationships are Key to the Implementation of HIV Care Engagement Interventions with Transgender Women of Color.
  10. A Longitudinal Cohort Study of HIV-Negative Transgender Women of Color in New York City: The TURNNT (‘Trying to Understand Relationships, Networks and Neighborhoods among Transgender women of color’) Study
  11. Identifying Opportunities for Collaboration Across the Social Sciences to Reach the 10-10-10: A Multilevel Approach.
  12. Relationship Stigma and HIV Risk Behavior Among Cisgender Men Partnered with Transgender Women: The Moderating Role of Sexual Identity.
  13. "Some of us, we don't know where we're going to be tomorrow." Contextual factors affecting PrEP use and adherence among a diverse sample of transgender women in San Francisco.
  14. Developing Correctional Policy, Practice, and Clinical Care Considerations for Incarcerated Transgender Patients Through Collaborative Stakeholder Engagement.
  15. The Psychedelic Renaissance and the limitations of a White-dominant medical framework
  16. Evidence for the Model of Gender Affirmation: The Role of Gender Affirmation and Healthcare Empowerment in Viral Suppression Among Transgender Women of Color Living with HIV.
  17. Medical Mistrust and PrEP Perceptions Among Transgender Women: A Cluster Analysis.
  18. Optimising HIV programming for transgender women in Brazil.
  19. Commitment, interpersonal stigma, and mental health in romantic relationships between transgender women and cisgender male partners.
  20. From erasure to opportunity: a qualitative study of the experiences of transgender men around pregnancy and recommendations for providers.
  21. Challenges and opportunities for gender-affirming healthcare for transgender women in prison.
  22. Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples.
  23. The Transgender Women of Color Initiative: Implementing and Evaluating Innovative Interventions to Enhance Engagement and Retention in HIV Care
  24. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices.
  25. Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis.
  26. Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices.
  27. PrEP adherence among trans women in Brazil-access needed for this key population - Authors' reply.
  28. 'You should build yourself up as a whole product': Transgender female identity in Lima, Peru.
  29. Acceptability and Feasibility of HIV Self-Testing Among Transgender Women in San Francisco: A Mixed Methods Pilot Study.
  30. Adult development and quality of life of transgender and gender nonconforming people.
  31. Barriers to healthcare for transgender individuals.
  32. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.
  33. In the name of brevity: The problem with binary HIV risk categories.
  34. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
  35. Syndemics and gender affirmation: HIV sexual risk in female-to-male trans masculine adults reporting sexual contact with cisgender males.
  36. Transgender men who experienced pregnancy after female-to-male gender transitioning.
  37. Becoming Janet Mock. [Review of the book Redefining realness: My path to womanhood, identity, love and so much more., by J. Mock]
  38. Correlates of antiretroviral adherence and viral load among transgender women living with HIV.
  39. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus.
  40. Racial/ethnic disparities in history of incarceration, experiences of victimization, and associated health indicators among transgender women in the U.S.
  41. Gender Affirmation: A Framework for Conceptualizing Risk Behavior among Transgender Women of Color.
  42. Transgender women of color: discrimination and depression symptoms.
  43. Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus.
  44. HIV/AIDS programming in the United States: considerations affecting transgender women and girls.
  45. Antiretroviral therapy adherence among transgender women living with HIV.
  46. "There's no pamphlet for the kind of sex I have": HIV-related risk factors and protective behaviors among transgender men who have sex with nontransgender men.
  47. Informing interventions: the importance of contextual factors in the prediction of sexual risk behaviors among transgender women.
  48. Student responsiveness to women's and gender studies classes: The importance of initial student attitudes and classroom relationships
  49. Men who have sex with transgender women: challenges to category-based HIV prevention.
  50. The effects of prior attitudes and attitude importance on attitude change and class impact in women’s and gender studies